drugset / Trial / NCT03850834

Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject

NCT03850834

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the safety, tolerability and pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Chinese healthy subjects

Timeline

Start
2019-03-10
Primary completion
2019-05-31
Completion
2019-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ammoxetine Unknown 15 mg
Subject Ammoxetine Unknown 30 mg
Subject Ammoxetine Unknown 45 mg

Indications